Product Details
Source
Biotinylated Monoclonal Mouse Anti-Human-IgG Antibody, Mouse IgG1 (6F11C8) is a mouse monoclonal antibody derived from hybridoma cells fused with SP2/0 myeloma cells and murine B lymphocytes.
Antibody Type
Hybridoma Monoclonal
Clone
6F11C8
Isotype
Mouse IgG1, Kappa
Host Species
Mouse
Reactivity
Human IgG Fc (IgG1, IgG2, IgG3, IgG4)
Immunogen
Human-IgG-Fc
Conjugate
Biotin
Specificity
Specifically binds to the Fc region of human IgG without recognizing Fab fragments or non-human IgG.
Application
ApplicationRecommended UsageELISA1:300-1:3000Cross Verification
No cross-reactivity in ELISA with
human IgM, human IgA1, cynomolgus IgG1, rabbit IgG, or His-tagged proteins.Purification
Protein A purified / Protein G purified.
Concentration
Please refer to the Certificate of Analysis (CoA).
Form
Lyophilized
Formulation
Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.
Please contact us for customized product forms or formulations.
Reconstitution
Please refer to the Certificate of Analysis (CoA) for specific instructions.
Shipping
Lyophilized product is shipped at ambient temperature.
Storage
For long term storage, the product should be stored in a lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
Customers Also Viewed
Performance Data
Bioactivity-ELISA

Immobilized Human IgG1 at 1 μg/mL (100 μL/well) can bind Biotinylated Monoclonal Mouse Anti-Human-IgG Antibody, Mouse IgG1 (6F11C8) with a linear range of 0.2–16 ng/mL in ELISA (QC tested).
Protocol
Immobilized Human IgG2, IgG3, and IgG4 at 1 μg/mL (100 μL/well) can bind Biotinylated Monoclonal Mouse Anti-Human-IgG Antibody, Mouse IgG1 (6F11C8) (Cat. No. IGG-BLY69) with a linear range of 0.1–16 ng/mL in ELISA (Routinely tested).
Protocol
Customer Reviews Writing Reviews

Background
Recent Advances
- English Name:
Immunoglobulin G
- Category:
- Approved Drugs:
1 Details
- Drugs in Clinical Trials:
7 Details
- Highest Development Stage:
Approved



















